Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges

How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries, various approaches have been used to identify and measure the efficacy and safety of CM. However, the high-quality evidence related to CM that produced in China is still rare. Over the recent years, evidence-based medicine (EBM) has been increasingly applied to CM, strengthening its theoretical basis. This paper reviews the past and present state of CM, analyzes the status quo, challenges and opportunities of basic research, clinical trials, systematic reviews, clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China, pointing out how EBM can help to make CM more widely used and recognized worldwide.

[1]  H. Cramer,et al.  Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care: Systematic Review and Meta-Analysis: Erratum , 2016, Medicine.

[2]  E. Ernst,et al.  Heavy metals in traditional Chinese medicines: A systematic review , 2001, Clinical pharmacology and therapeutics.

[3]  Qian Liu,et al.  A turning point for clinical research in China? , 2013, The Lancet.

[4]  E. Ernst.  Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review , 2002, Journal of internal medicine.

[5]  Saijuan Chen,et al.  Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Fugh-Berman,et al.  Herb-drug interactions: review and assessment of report reliability. , 2001, British journal of clinical pharmacology.

[7]  Justin C.Y. Wu,et al.  Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care , 2016, Medicine.

[8]  Z. Ying.  Assessment of Systematic Reviews and Meta-analyses on Traditional Chinese Medicine Published in Chinese Journals , 2007 .

[9]  Baoyan Liu,et al.  Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial , 2013, Evidence-based complementary and alternative medicine : eCAM.

[10]  Bao-yan Liu,et al.  Extending the CONSORT Statement to moxibustion. , 2013, Journal of integrative medicine.

[11]  Mao Bing.  Assessing the Quality of Reporting of Randomized Controlled Trials in Traditional Chinese Medicine , 2007 .

[12]  Edzard Ernst,et al.  Review of randomised controlled trials of traditional Chinese medicine , 1999, BMJ.

[13]  Justin C.Y. Wu,et al.  Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews , 2015, Scientific Reports.

[14]  Hai-tao Xiao,et al.  Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings. , 2015, The American journal of Chinese medicine.

[15]  Jing Luo,et al.  Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: an overview of systematic reviews. , 2015, The American journal of Chinese medicine.

[16]  D. Moher,et al.  Consolidated Standards for Reporting Trials of Traditional Chinese Medicine (CONSORT for TCM) (For Solicitation of Comments) , 2007 .

[17]  J. Chen,et al.  Status and thoughts of Chinese patent medicines seeking approval in the US market , 2014, Chinese Journal of Integrative Medicine.

[18]  E. E. Frcp,et al.  Adverse effects of unconventional therapies in the elderly: A systematic review of the recent literature , 2002, Journal of the American Aging Association.

[19]  Sombat Muengtaweepongsa,et al.  Chinese Medicine Neuroaid Efficacy on Stroke Recovery: A Double-Blind, Placebo-Controlled, Randomized Study , 2013, Stroke.

[20]  Pin,et al.  Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care Systematic Review And Meta-analysis , 2016 .

[21]  Chong-Zhi Wang,et al.  Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. , 2014, The Journal of clinical endocrinology and metabolism.

[22]  Guanjian Liu,et al.  Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional chinese medicine RCTs: A review of 3159 RCTs identified from 260 systematic reviews , 2011, Trials.

[23]  D. Spence.  Evidence based medicine is broken , 2014, BMJ : British Medical Journal.

[24]  L. Bouter,et al.  Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis , 2008, BMJ : British Medical Journal.

[25]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[26]  W. Yao,et al.  A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. , 2013, Journal of the American College of Cardiology.

[27]  B. Cao,et al.  Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza , 2011, Annals of Internal Medicine.

[28]  L. Jian-ping,et al.  Chinese medicinal herbs for chronic hepatitis B: a systematic review , 2001 .

[29]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[30]  D. Moher,et al.  Randomized trials published in some Chinese journals: how many are randomized? , 2009, Trials.

[31]  K. Hirji,et al.  No short-cut in assessing trial quality: a case study , 2009, Trials.

[32]  Jian-ping Liu,et al.  Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2013, PloS one.

[33]  Edzard Ernst,et al.  Panax ginseng: An Overview of the Clinical Evidence , 2010 .

[34]  E. Ernst.  Adverse effects of herbal drugs in dermatology , 2000, The British journal of dermatology.

[35]  Yong Huang,et al.  The effectiveness of acupuncture in postoperative gastroparesis syndrome--a systematic review and meta-analysis. , 2014, Complementary therapies in medicine.

[36]  Romina Brignardello-Petersen,et al.  [Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise]. , 2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[37]  [Methodological quality assessment of systematic reviews correlated to traditional Chinese medicine published in China]. , 2011, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[38]  Jian-ping Liu,et al.  Chinese herbal medicine for gout: a systematic review of randomized clinical trials , 2013, Clinical Rheumatology.

[39]  [Quality appraisal of systematic reviews or meta-analysis on traditional Chinese medicine published in Chinese journals]. , 2007, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[40]  H. McIntosh,et al.  Chinese medicinal herbs for chronic hepatitis B. , 2000, The Cochrane database of systematic reviews.

[41]  Xin-feng Guo,et al.  Efficacy and Safety of Tai Chi for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2014, PloS one.

[42]  D. Capuzzi,et al.  Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. , 2008, The American journal of cardiology.

[43]  S. Greenfield,et al.  The effect of complementary and alternative medicine on the quality of life of cancer survivors: a systematic review and meta-analyses. , 2013, Complementary therapies in medicine.

[44]  David Evans,et al.  Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. , 2003, Journal of clinical nursing.

[45]  F. Song,et al.  A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement. , 2017, Annals of internal medicine.

[46]  E. Ernst.  Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence , 2003, European Journal of Pediatrics.

[47]  Li Ting,et al.  Clinical Trials of Traditional Chinese Medicine in China: Status and Evaluation , 2005 .